• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 MINILOC SAFETY INFUSION SET 20G X 1 IN WITH Y-SITE; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 MINILOC SAFETY INFUSION SET 20G X 1 IN WITH Y-SITE; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number N/A
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/15/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that when priming the miniloc safety needle there is leakage.Leakage from the needle.No other information was provided.
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The manufacturer has received the sample and will evaluate.Results are expected soon.
 
Event or Problem Description
It was reported that when priming the miniloc safety needle there is leakage.Leakage from the needle.No other information was provided.
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The product returned for evaluation was one segment of digital video which depicted a 20ga x 1¿ miniloc safety infusion set.The depicted portion of the device included the needle and needle housing.The clear safety sleeve was in place over the needle.The device was being flushed.Clear infusate was visible emanating from both the top and bottom of the clear sleeve.Infusate was visible emanating from the top of the sleeve; however, it could not be determined if this was caused by a leak in the vicinity of the housing or backflow from the tip of the needle.Consequently, this complaint is inconclusive at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MINILOC SAFETY INFUSION SET 20G X 1 IN WITH Y-SITE
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city UT 84116
Manufacturer Contact
johanna de oliveira
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key18274975
Report Number3006260740-2023-05523
Device Sequence Number20623141
Product Code FPA
UDI-Device Identifier00801741048029
UDI-Public(01)00801741048029
Combination Product (Y/N)N
Initial Reporter CountryMO
PMA/510(K) Number
K050600
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 02/16/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/26/2025
Device Model NumberN/A
Device Catalogue Number0682010
Device Lot NumberASGRFC114
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/15/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/15/2023
Supplement Date Received by Manufacturer02/16/2024
Initial Report FDA Received Date12/06/2023
Supplement Report FDA Received Date02/26/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/01/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-